等待开盘 12-20 09:30:00 美东时间
-0.269
-1.40%
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Keefe, Bruyette & Woods analyst Ryan Lynch maintains Fidus Investment (NASDAQ:FDUS) with a Outperform and lowers the price target from $21.5 to $21.
11-11 01:27
Fidus Investment (NASDAQ:FDUS) reported quarterly earnings of $0.50 per share which met the analyst consensus estimate. This is a 18.03 percent decrease over earnings of $0.61 per share from the same period last year.
11-07 05:09
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Fidus Investment Corporation (NASDAQ: FDUS) announced on October 30, 2025, that it will release its third quarter 2025 financial results on November 6, 2025. A conference call to discuss the results will be held at 9:00am ET on November 7, 2025. Participants can dial (844) 808-7136 (U.S.) or (412) 317-0534 (international). A live webcast will be available at https://investor.fdus.com/news-events/events-presentations, with replays accessible later...
10-30 20:05
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从19美元升至20美元;Ascendiant Capital:维持Plus Therapeutics"买入"评级,目标价从20.5美元升至21美元
10-07 15:04
Fidus Investment shares are trading lower after the company priced a $100 milli...
10-02 04:40
Fidus Investment Corporation has priced an additional $100 million of 6.750% notes due 2030, bringing the total outstanding aggregate principal amount to $200 million. The notes will mature on March 19, 2030, with interest payable semi-annually. Fidus plans to use the proceeds to redeem its outstanding 4.75% notes due 2026. The offering is expected to close on October 3, 2025, subject to customary closing conditions. Raymond James & Associates, I...
10-01 20:35
Clear Street analyst Mickey Schleien initiates coverage on Fidus Investment (NASDAQ:FDUS) with a Buy rating and announces Price Target of $21.
09-05 17:34
Keefe, Bruyette & Woods analyst Ryan Lynch maintains Fidus Investment (NASDAQ:FDUS) with a Market Perform and raises the price target from $20 to $21.5.
08-11 18:42